Guidelines

New consensus on thyroid eye disease prompts some debate


 

Consensus statement not a guideline

The groups noted that the consensus statement is not meant to be a clinical practice guideline and was not written to “establish a standard of care, replace sound clinical judgment, or capture all nuances likely to be present in any particular patient,” and “specific outcomes are not guaranteed.”

What the statement is intended for is to “provide a concise and timely appraisal of a rapidly changing therapeutic arena” for practicing endocrinologists, they explained.

Overall, the authors recommend an individualized management approach, based on factors ranging from disease severity, duration, its impact on daily living, patient age, comorbidities, and importantly, the costs of therapies.

Ultimately, patient satisfaction is essential in TED management, Dr. Burch added.

“Consideration of the impact of TED on patient’s satisfaction with their appearance and visual functioning is a key component in management decisions concerning TED.”A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Don’t be afraid of weight gain with hyperthyroid treatment
MDedge Endocrinology
Stopping levothyroxine in subclinical hypothyroidism safe, feasible
MDedge Endocrinology
Children with low-risk thyroid cancer can skip radioactive iodine
MDedge Endocrinology
Safe to expand limits of active surveillance in thyroid cancer?
MDedge Endocrinology
New EU guidelines: Individualize care for thyroid cancer in kids
MDedge Endocrinology
USPSTF holds firm on postmenopausal hormone recommendations
MDedge Endocrinology
Thyroid nodule volume reduction correlates with energy in ablation
MDedge Endocrinology
‘Game changer’: Thyroid cancer recurrence no higher with lobectomy
MDedge Endocrinology
Lifestyle choices could curb genetic risk for thyroid cancer
MDedge Endocrinology
Guidance updated for congenital hypothyroidism screening, management
MDedge Endocrinology